STONY BROOK, NY--(Marketwired - October 29, 2015) - Applied DNA Sciences, Inc. (
James Hayward, CEO, Applied DNA Sciences, stated, "The report is a blatant and transparent attempt by parties to profit from an immediate and precipitous decline in the company's share price through the use of an opinion piece published anonymously and laden with innuendo and the use of selective historical information. It is also important for investors in Applied DNA Sciences and other stakeholders to carefully consider the statement the author made on the first page of his/her editorial attacking the company: 'I am/we are short APDN. I wrote this article myself, and it expresses my own opinions.'"
About Applied DNA Sciences
Applied DNA Sciences makes life real and safe by providing biotechnology-driven solutions to help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Patented botanical DNA solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature DNA is at the heart of a family of uncopyable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators.
Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW.
Forward Looking Statements
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 15, 2014, as amended on March 6, 2015, and our subsequent quarterly reports on Form 10-Q filed on February 9, 2015, May 11,2015 and August 10, 2015, which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.
Contact Information:
Investor contact:
Debbie Bailey
631-240-8817
debbie.bailey@adnas.com
Sanjay M. Hurry
Lippert/Heilshorn & Associates, Inc.
212-838-3777
shurry@lhai.com
media contact:
Susan Forman
Dian GrieselInt'l.
212-825-3210
sforman@dgicomm.com
web: www.adnas.com
twitter: @APDN